+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization

  • PDF Icon

    Report

  • 412 Pages
  • May 2023
  • Region: Global
  • Howe Sound Research
  • ID: 5312233

Companion Diagnostics and Liquid Biopsy drive market growth. New cancer diagnostic segments emerging

A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. The publisher includes a special segment Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 120 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • Personalized medicine
  • Pharmacogenomics
  • Liquid biopsy
  • Emergence of new economies with large markets
  • Greater understanding of the role of genetic material in Disease and Health

Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. 

In addition customization work, breakouts for particular segments, assistance and support is included free of charge with every report.

"Molecular Diagnostics for Cancer. Markets Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides and Customization" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help understand test pricing in detail. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. 

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Table of Contents

1 Market Guides
1.1 Cancer MDx - Strategic Situation Analysis
1.2 Guide for Executives, Marketing, and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition
2.1 What are Molecular Diagnostics?
2.2 The Diagnostics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 Methodology
2.4.1 Methodology
2.4.2 Sources
2.4.3 Authors
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics

3 Market Overview
3.1 Market Segments
3.1.1 Traditional Market Segmentation
3.1.2 Laboratory Focus and Segmentation
3.2 Industry Structure
3.2.1 Hospital Testing Share
3.2.2 Economies of Scale
3.2.3 Physician Office Labs
3.2.4 Physicians and POCT

4 Market Trends
4.1 Factors Driving Growth
4.1.1 New Diagnostics Create New Markets
4.1.2 New Roles for Diagnostics
4.1.3 The Aging Effect
4.1.4 Expanding the Pharmaceutical Toolbox
4.1.5 Regulatory Retreat
4.2 Factors Limiting Growth
4.2.1 Falling Prices
4.2.2 Lower Costs
4.2.3 Wellness has a Downside
4.3 Instrumentation, Automation and Diagnostic Trends
4.3.1 Traditional Automation and Centralization
4.3.2 The New Automation, Decentralization and Point Of Care
4.3.3 Instruments Key to Market Share
4.3.4 Bioinformatics Plays a Role
4.3.5 PCR Takes Command
4.3.6 Next Generation Sequencing Fuels a Revolution
4.3.7 NGS Impact on Pricing
4.3.8 Whole Genome Sequencing, A Brave New World
4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
4.3.10 Shifting Role of Diagnostics
4.3.11 Multiplexing and Foundation One
4.3.12 Pharmacogenomics Technology
4.3.13 Gene Editing and Gene Therapy

5 Molecular Diagnostics Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
5.2 Sema4 Exiting Reproductive Health Screening
5.3 Thermo Fisher Introduces Cancer Profiling Assay
5.4 Genomic Test IDs Cysts Likely to Progress to Cancer
5.5 Naveris to Commercialize Virus-Related Cancer Tests
5.6 Larger Liquid Biopsy Panels Loom
5.7 Halo Diagnostics to Offer Genomic Profiling Tests
5.8 BillionToOne Raises $125M
5.9 Local Cancer Genomic Profiling Options Grow
5.10 German MDx Firm Mainz Biomed Raises $10M in IPO
5.11 Guardant Health Q3 Revenues Up 27 Percent
5.12 BforCure Raises $2.3M to Adapt Rapid PCR Platform for Cancer Detection
5.13 Nucleix to Invest in Early-Stage Lung Cancer Dx
5.14 Labcorp, GeneCentric Partnering on Development of RNA-Based Cancer Diagnostics
5.15 Grail Gets Approval for Galleri Multicancer Test
5.16 Finnish Firms to Form Point-of-Care Testing Firm
5.17 Datar Cancer Genetics Expands to Dx and Screening
5.18 HTG Molecular Diagnostics: HTG Transcriptome Panel
5.19 PacBio's Omniome Acquisition Shortens Path to Clinical
5.20 Invitae to Acquire Genosity for $200M
5.21 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test
5.22 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience
5.23 Natera Revenues Grow 35 Percent
5.24 AnchorDx Closes $40M Financing Round
5.25 Exact Sciences Strategy for End-to-End Cancer Testing
5.26 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch

6 Profiles of Key MDx Companies
6.1 10x Genomics, Inc.
6.2 Abbott Laboratories
6.3 AccuraGen Inc.
6.4 Adaptive Biotechnologies
6.5 Aethlon Medical
6.6 Agilent/Dako
6.7 Anchor Dx
6.8 ANGLE plc
6.9 ARUP Laboratories
6.10 AVIVA Systems Biology
6.11 Baylor Miraca Genetics Laboratories
6.12 Beckman Coulter Diagnostics
6.13 Becton, Dickinson and Company
6.14 BGI Genomics Co. Ltd
6.15 BillionToOne
6.16 Bioarray Genetics
6.17 Biocartis
6.18 Biocept, Inc.
6.19 Biodesix Inc.
6.20 BioFluidica
6.21 BioGenex
6.22 BioIVT
6.23 Biolidics Ltd
6.24 bioMérieux Diagnostics
6.25 Bioneer Corporation
6.26 Bio-Rad Laboratories, Inc
6.27 Bio-Reference Laboratories
6.28 Bio-Techne
6.29 Bioview
6.30 Bolidics
6.31 Boreal Genomics
6.32 Bristol-Myers Squibb
6.33 Burning Rock
6.34 Cardiff Oncology
6.35 Caris Molecular Diagnostics
6.36 Castle Biosciences, Inc.
6.37 Celemics
6.38 CellCarta
6.39 CellMax Life
6.40 Cepheid (Danaher)
6.41 Charles River Laboratories
6.42 Circulogene
6.43 Cizzle Biotech
6.44 Clinical Genomics
6.45 Cytolumina Technologies Corp.
6.46 Datar Cancer Genetics Limited
6.47 Diagnologix LLC
6.48 Diasorin S.p.A.
6.49 Dxcover
6.50 Enzo Biochem
6.51 Epic Sciences
6.52 Epigenomics AG
6.53 Eurofins Scientific
6.54 Exact Sciences
6.55 Fabric Genomics
6.56 Fluxion Biosciences
6.57 Freenome
6.58 FUJIFILM Wako Diagnostics
6.59 Fulgent Genetics
6.60 Fyr Diagnostics
6.61 GeneFirst Ltd.
6.62 Genetron Holdings
6.63 GenomOncology
6.64 GILUPI Nanomedizin
6.65 Guardant Health
6.66 HansaBiomed
6.67 HeiScreen
6.68 Helomics
6.69 HTG Molecular Diagnostics
6.70 iCellate
6.71 ICON PLC
6.72 Illumina
6.73 Incell Dx
6.74 Inivata
6.75 INOVIQ
6.76 Integrated Diagnostics
6.77 Invitae Corporation
6.78 Invivogen
6.79 Invivoscribe
6.80 Janssen Diagnostics
6.81 Lunglife AI Inc
6.82 MDNA Life SCIENCES, Inc.
6.83 MDx Health
6.84 Menarini Silicon Biosystems
6.85 Mesa Laboratories, Inc.
6.86 Millipore Sigma
6.87 Miltenyi Biotec
6.88 miR Scientific
6.89 Myriad Genetics/Myriad RBM
6.90 NantHealth, Inc.
6.91 Natera
6.92 NeoGenomics
6.93 NGeneBio
6.94 Novogene Bioinformatics Technology Co., Ltd.
6.95 Oncocyte
6.96 OncoDNA
6.97 Ortho Clinical Diagnostics
6.98 Oxford Nanopore Technologies
6.99 PamGene
6.100 Panagene
6.101 Perkin Elmer
6.102 Personal Genome Diagnostics
6.103 Personalis
6.104 Precipio
6.105 Precision Medicine Group
6.106 PrecisionMed
6.107 Predicine
6.108 Promega
6.109 Qiagen
6.110 Rarecells SAS
6.111 RareCyte
6.112 Roche Molecular Diagnostics
6.113 Screencell
6.114 Sema4 Holdings
6.115 Sense Biodetection
6.116 Siemens Healthineers
6.117 simfo GmbH
6.118 Singlera Genomics Inc.
6.119 Singulomics
6.120 SkylineDx
6.121 Standard BioTools
6.122 Sysmex Inostics
6.123 Tempus Labs, Inc.
6.124 Thermo Fisher Scientific Inc.
6.125 Todos Medical
6.126 Variantyx
6.127 Veracyte
6.128 Volition
6.129 Vortex Biosciences
6.130 Vyant Bio
6.131 Zhejiang Orient Gene Biotech

7 The Global Market for MDx Cancer
7.1 MDx Cancer - Global Market Overview by Country
7.1.1 Table - Global Market by Country
7.1.2 Chart - Global Market by Country
7.2 Global Market by Cancer Type - Overview
7.2.1 Table - Global Market by Cancer Type
7.2.2 Chart - Global Market by Cancer Type - Base/Final Comparison
7.2.3 Chart - Global Market by Cancer Type - Base Year
7.2.4 Chart - Global Market by Cancer Type -Final Year
7.2.5 Chart - Global Market by Cancer Type - Share by Year
7.2.6 Chart - Global Market by Cancer Type - Segment Growth
7.3 Global Market by Product Type - Overview
7.3.1 Table - Global Market by Product Type
7.3.2 Chart - Global Market by Product Type - Base/Final Comparison
7.3.3 Chart - Global Market by Product Type - Base Year
7.3.4 Chart - Global Market by Product Type -Final Year
7.3.5 Chart - Global Market by Product Type - Share by Year
7.3.6 Chart - Global Market by Product Type - Segment Growth
7.4 Global Market by Place - Overview
7.4.1 Table - Global Market by Place
7.4.2 Chart - Global Market by Place - Base/Final Comparison
7.4.3 Chart - Global Market by Place - Base Year
7.4.4 Chart - Global Market by Place -Final Year
7.4.5 Chart - Global Market by Place - Share by Year
7.4.6 Chart - Global Market by Place - Segment Growth

8 Global Market by Cancer Type
8.1 MDx Breast Cancer
8.1.1 Table Breast Cancer Testing - by Country
8.1.2 Chart - Breast Cancer Testing Growth
8.2 MDx Colorectal Cancer
8.2.1 Table Colorectal Cancer Testing - by Country
8.2.2 Chart - Colorectal Cancer Testing Growth
8.3 MDx Cervical Cancer
8.3.1 Table Cervical Cancer Testing - by Country
8.3.2 Chart - Cervical Cancer Testing Growth
8.4 MDx Lung Cancer
8.4.1 Table Lung Cancer Testing - by Country
8.4.2 Chart - Lung Cancer Testing Growth
8.5 MDx Prostate
8.5.1 Table Prostate Testing - by Country
8.5.2 Chart - Prostate Testing Growth
8.6 MDx Melanoma Cancer
8.6.1 Table Melanoma Cancer Testing - by Country
8.6.2 Chart - Melanoma Cancer Testing Growth
8.7 MDx Blood
8.7.1 Table Blood Testing - by Country
8.7.2 Chart - Blood Testing Growth
8.8 MDx Companion Dx Development
8.8.1 Table Companion Dx Development - by Country
8.8.2 Chart - Companion Dx Development Growth
8.9 MDx Other Cancer
8.9.1 Table Other Cancer Testing - by Country
8.9.2 Chart - Other Cancer Testing Growth

9 Global Market by Product Type
9.1 MDx Instruments
9.1.1 Table Instruments - by Country
9.1.2 Chart - Instruments Growth
9.2 MDx Reagents
9.2.1 Table Reagents - by Country
9.2.2 Chart - Reagents Growth
9.3 MDx Software and Services
9.3.1 Table Software and Services - by Country
9.3.2 Chart - Software and Services Growth

10 Global Market by Place
10.1 MDx Clinical Laboratory
10.1.1 Table Clinical Laboratory - by Country
10.1.2 Chart - Clinical Laboratory Growth
10.2 MDx Pharmaceutical
10.2.1 Table Pharmaceutical - by Country
10.2.2 Chart - Pharmaceutical Growth
10.3 MDx Research
10.3.1 Table Research - by Country
10.3.2 Chart - Research Growth

11 Cancer Treatment and Trials
11.1 FDA Cancer Drug Approvals by Year
11.2 Clinical Trials Started 2010 to 2016
11.3 Prevalence of Cancer Treatments - 2015

12 Appendices
12.1 United States Medicare System: 2022 Clinical Laboratory Fees Schedule
12.2 FDA Approved Human Genetic Tests
12.3 FDA Approved Microbial Tests
12.4 FDA Approved Pharmacogenomics Tests

List of Tables
Table 2 Clinical Laboratory Departments and Segments
Table 3 Laboratory Management Focus - Different Approaches
Table 4 Key Segmentation Variables Going Forward
Table 5 Five Factors Driving Growth
Table 6 Factors Limiting Growth
Table 8 Seven Key Diagnostic Laboratory Technology Trends
Table 8 Global MDx Cancer Market by Region
Table 9 Global Market by Cancer Type
Table 10 Global Market by Product Type
Table 11 Global Market by Place
Table 12 MDx Breast Cancer by Country
Table 13 MDx Colorectal Cancer by Country
Table 14 Cervical Cancer Testing by Country
Table 15 Lung Cancer Testing by Country
Table 16 Prostate Testing by Country
Table 17 Melanoma Cancer Testing by Country
Table 18 MDx Blood by Country
Table 19 MDx Companion Dx Development by Country
Table 20 MDx Other Cancer Testing by Country
Table 21 MDx Instruments by Country
Table 22 MDx Reagents by Country
Table 23 Software and Services by Country
Table 24 MDx Clinical Laboratory by Country
Table 25 MDx Pharmaceutical by Country
Table 26 Research by Country
Table 27 2022 Clinical Lab Fee Schedule

List of Figures
Figure 1 Global Healthcare Spending
Figure 2 The Lab Test Pie
Figure 4 Population by Age Group
Figure 5 Health Care Consumption by Age
Figure 6 Cancer Incidence - Age at Diagnosis
Figure 1 Centralized vs. Decentralized Laboratory Service
Figure 2 A Highly Multiplexed Syndromic Testing Unit
Figure 3 The Real Cost to Sequence the Human Genome
Figure 4 The Codevelopment Process
Figure 7 Comparing MDx Diagnostic and Traditional Testing
Figure 12 Global Market Shares Base Year
Figure 13 MDx Market by Cancer - Base vs. Final
Figure 14 Cancer Market Base Year
Figure 15 Cancer Market Final Year
Figure 16 MDx Cancer Share by Year
Figure 17 MDx Cancer Segment Growth Rates
Figure 18 MDx Market by Product - Base vs. Final
Figure 19 Product Market Base Year
Figure 20 Product Market Final Year
Figure 21 MDx Product Share by Year
Figure 22 MDx Product Segment Growth Rates
Figure 23 MDx Market by Place - Base vs. Final
Figure 24 Place Market Base Year
Figure 25 Place Market Final Year
Figure 26 MDx Place Share by Year
Figure 27 MDx Place Segment Growth Rates
Figure 28 Breast Cancer Testing Growth
Figure 29 Colorectal Cancer Testing Growth
Figure 30 Cervical Cancer Testing Growth
Figure 31 Lung Cancer Testing Growth
Figure 32 Prostate Testing Growth
Figure 33 Melanoma Cancer Testing Growth
Figure 34 Blood Testing Growth
Figure 35 Companion Dx Development Growth
Figure 36 Other Cancer Testing Growth
Figure 37 Instruments Growth
Figure 38 Reagents Growth
Figure 39 Software and Services Growth
Figure 40 Clinical Laboratory Growth
Figure 41 Pharmaceutical Growth
Figure 42 Research Growth
Figure 43 FDA Cancer Drug Approvals by Year
Figure 44 Clinical Trials for Immunotherapy by Year
Figure 45 Pie Chart of Prevalence of Cancer Treatments

Companies Mentioned

  • 10x Genomics, Inc.
  • Abbott Laboratories
  • AccuraGen Inc.
  • Adaptive Biotechnologies
  • Aethlon Medical
  • Agilent/Dako
  • Anchor Dx
  • ANGLE plc
  • ARUP Laboratories
  • AVIVA Systems Biology
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BGI Genomics CoLtd
  • BillionToOne
  • Bioarray Genetics
  • Biocartis
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • BioIVT
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Reference Laboratories
  • Bio-Techne
  • Bioview
  • Bolidics
  • Boreal Genomics
  • Bristol-Myers Squibb
  • Burning Rock
  • Cardiff Oncology
  • Caris Molecular Diagnostics
  • Castle Biosciences, Inc.
  • Celemics
  • CellCarta
  • CellMax Life
  • Cepheid (Danaher)
  • Charles River Laboratories
  • Circulogene
  • Cizzle Biotech
  • Clinical Genomics
  • Cytolumina Technologies Corp.
  • Datar Cancer Genetics Limited
  • Diagnologix LLC
  • Diasorin S.p.A.
  • Dxcover
  • Enzo Biochem
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Exact Sciences
  • Fabric Genomics
  • Fluxion Biosciences
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fulgent Genetics
  • Fyr Diagnostics
  • GeneFirst Ltd.
  • Genetron Holdings
  • GenomOncology
  • GILUPI Nanomedizin
  • Guardant Health
  • HansaBiomed
  • HeiScreen
  • Helomics
  • HTG Molecular Diagnostics
  • iCellate
  • ICON PLC
  • Illumina
  • Incell Dx
  • Inivata
  • INOVIQ
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivogen
  • Invivoscribe
  • Janssen Diagnostics
  • Lunglife AI Inc
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Menarini Silicon Biosystems
  • Mesa Laboratories, Inc.
  • Millipore Sigma
  • Miltenyi Biotec
  • miR Scientific
  • Myriad Genetics/Myriad RBM
  • NantHealth, Inc.
  • Natera
  • NeoGenomics
  • NGeneBio
  • Novogene Bioinformatics Technology Co., Ltd.
  • Oncocyte
  • OncoDNA
  • Ortho Clinical Diagnostics
  • Oxford Nanopore Technologies
  • PamGene
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • Precision Medicine Group
  • PrecisionMed
  • Predicine
  • Promega
  • Qiagen
  • Rarecells SAS
  • RareCyte
  • Roche Molecular Diagnostics
  • Screencell
  • Sema4 Holdings
  • Sense Biodetection
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • Singulomics
  • SkylineDx
  • Standard BioTools
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Todos Medical
  • Variantyx
  • Veracyte
  • Volition
  • Vortex Biosciences
  • Vyant Bio
  • Zhejiang Orient Gene Biotech

Methodology

Loading
LOADING...